Although all this growth is encouraging, it is also straining global manufacturing capacities. Biopharma manufacturers are under pressure to find innovative platform technologies to bring products to ...

The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...

Upstream process intensification using perfusion cell culture has become a necessity for meeting today’s demand in monoclonal antibodies (mAbs) bioprocessing. By sustaining higher viable cell ...